Dreon, D. M., et al. “Oral Contraceptive Use and Increased Plasma Concentration of C-reactive Protein”. Life Sciences 73, no. 10 (2003): 1245–52.

Ervin, K. S., et al. “Estrogen Involvement in Social Behavior in Rodents: Rapid and Long- Term Actions”. Hormones and Behavior 74 (2015): 53–76.

Fröhlich, M., et al. “Oral Contraceptive Use Is Associated with a Systemic Acute Phase Response”. Fibrinolysis and Proteolysis 13, no. 6 (1999): 239–44.

Graham, B. M., et al. “Blockade of Estrogen by Hormonal Contraceptives Impairs Fear Extinction in Female Rats and Women”. Biological Psychiatry 73, no. 4 (2013): 371–78.

Kabat-Zinn, J., et al. “Effectiveness of a Meditation-Based Stress Reduction Program in the Treatment of Anxiety Disorders”. American Journal of Psychiatry 149, no. 7 (1992): 936–43.

Kessler, R. C. “Epidemiology of Women and Depression”. Journal of Affective Disorders 74, no. 1 (2003): 5–13.

Klein, S. L., et al. “Sex Differences in Immune Responses”. Nature Reviews Immunology 16, no. 10 (2016): 626–38.

Kovats, S. “Estrogen Receptors Regulate Innate Immune Cells and Signaling Pathways”. Cellular Immunology 294, no. 2 (2015): 63–69.

Lakhan, S. E., et al. “Nutritional and Herbal Supplements for Anxiety and Anxiety-Related Disorders: A Systematic Review”. Nutrition Journal 9 (2010): 42.

Liu, X., et al. “Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet”. Journal of Agricultural and Food Chemistry 63, no. 36 (2015): 7885–95.

Maeng, L. Y., et al. “Sex Differences in Anxiety Disorders: Interactions Between Fear, Stress, and Gonadal Hormones”. Hormones and Behavior 76 (2015): 106–17.

Mao, J. J., et al. “Rhodiola Rosea Versus Sertraline for Major Depressive Disorder: A Randomized Placebo-Controlled Trial”. Phytomedicine 22, no. 3 (2015): 394–99.

Meier, T. B., et al. “Kynurenic Acid Is Reduced in Females and Oral Contraceptive Users: Implications for Depression”. Brain, Behavior, and Immunity 67 (2018): 59–64.

Miller, A. H., et al. “The Role of Inflammation in Depression: From Evolutionary Imperative to Modern Treatment Target”. Nature Reviews: Immunology 16, no. 1 (2015): 22–34.

Montoya, E. R., et al. “How Oral Contraceptives Impact Social-Emotional Behavior and Brain Function”. Trends in Cognitive Sciences 21, no. 2 (2017): 125–36.

Nehlig, A. “Effects of Coffee/Caffeine on Brain Health and Disease: What Should I Tell My Patients?” Practical Neurology 16, no. 2 (2016): 89–95.

Palmery, M., et al. “Oral Contraceptives and Changes in Nutritional Requirements”. European Review for Medical and Pharmacological Sciences 17, no. 13 (2013): 1804–13.